A carregar...

Combining AKT inhibition with chloroquine and gefitinib prevents compensatory autophagy and induces cell death in EGFR mutated NSCLC cells

Although non-small cell lung cancer (NSCLC) patients with EGFR mutation positive (EGFR M+) tumors initially respond well to EGFR tyrosine kinase inhibitor (TKI) monotherapy, the responses are usually incomplete. In this study we show that AKT inhibition, most importantly AKT2 inhibition, synergises...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bokobza, Sivan M., Jiang, Yanyan, Weber, Anika M., Devery, Aoife M., Ryan, Anderson J.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4148097/
https://ncbi.nlm.nih.gov/pubmed/24946858
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!